chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Electromyogram, Heart rate, Heart rate increased, Hypoaesthesia, Magnetic resonance imaging head
Clinical narrative: Post vaccine I have paresthesia and numbness in the face, arms and legs.  For the first several weeks I also had a rapid heart rate.  I have seen my primary care physician and a neurologist.; Post vaccine I have paresthesia and numbness in the face, arms and legs.  For the first several weeks I also had a rapid heart rate.  I have seen my primary care physician and a neurologist.  EMG and; Post vaccine I have paresthesia and numbness in the face, arms and legs.  For the first several weeks I also had a rapid heart rate.  I have seen my primary care physician and a neurologist.  EMG and; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jul2021 08:00 (Lot number: EW0183) at the age of 46 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PARAESTHESIA (non-serious) with onset 02Aug2021 08:00, outcome "not recovered", described as "Post vaccine I have paresthesia and numbness in the face, arms and legs.  For the first several weeks I also had a rapid heart rate.  I have seen my primary care physician and a neurologist."; HEART RATE INCREASED (non-serious), HYPOAESTHESIA (non-serious) all with onset 02Aug2021 08:00, outcome "not recovered" and all described as "Post vaccine I have paresthesia and numbness in the face, arms and legs.  For the first several weeks I also had a rapid heart rate.  I have seen my primary care physician and a neurologist.  EMG and". The events "post vaccine i have paresthesia and numbness in the face, arms and legs.  for the first several weeks I also had a rapid heart rate.  i have seen my primary care physician and a neurologist.", "post vaccine I have paresthesia and numbness in the face, arms and legs.  for the first several weeks i also had a rapid heart rate.  i have seen my primary care physician and a neurologist.  emg and" and "post vaccine i have paresthesia and numbness in the face, arms and legs.  for the first several weeks i also had a rapid heart rate.  i have seen my primary care physician and a neurologist.  emg and" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of paraesthesia, heart rate increased, hypoaesthesia.  Additional Information: The facility type vaccine was hospital. The patient had no allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging spinal, Nerve conduction studies, Paraesthesia, SARS-CoV-2 test
Clinical narrative: Post vaccine I have paresthesia and numbness in the face, arms and legs.  For the first several weeks I also had a rapid heart rate.  I have seen my primary care physician and a neurologist.; Post vaccine I have paresthesia and numbness in the face, arms and legs.  For the first several weeks I also had a rapid heart rate.  I have seen my primary care physician and a neurologist.  EMG and; Post vaccine I have paresthesia and numbness in the face, arms and legs.  For the first several weeks I also had a rapid heart rate.  I have seen my primary care physician and a neurologist.  EMG and; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jul2021 08:00 (Lot number: EW0183) at the age of 46 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PARAESTHESIA (non-serious) with onset 02Aug2021 08:00, outcome "not recovered", described as "Post vaccine I have paresthesia and numbness in the face, arms and legs.  For the first several weeks I also had a rapid heart rate.  I have seen my primary care physician and a neurologist."; HEART RATE INCREASED (non-serious), HYPOAESTHESIA (non-serious) all with onset 02Aug2021 08:00, outcome "not recovered" and all described as "Post vaccine I have paresthesia and numbness in the face, arms and legs.  For the first several weeks I also had a rapid heart rate.  I have seen my primary care physician and a neurologist.  EMG and". The events "post vaccine i have paresthesia and numbness in the face, arms and legs.  for the first several weeks I also had a rapid heart rate.  i have seen my primary care physician and a neurologist.", "post vaccine I have paresthesia and numbness in the face, arms and legs.  for the first several weeks i also had a rapid heart rate.  i have seen my primary care physician and a neurologist.  emg and" and "post vaccine i have paresthesia and numbness in the face, arms and legs.  for the first several weeks i also had a rapid heart rate.  i have seen my primary care physician and a neurologist.  emg and" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of paraesthesia, heart rate increased, hypoaesthesia.  Additional Information: The facility type vaccine was hospital. The patient had no allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19, FLUX
Symptoms: Eye pain, Headache, Sensory disturbance, Trigeminal nerve disorder
Clinical narrative: Trigeminal Nerve seems to be affected; Top of head on right side is sensitive to touch, right eye sensitive to touch, front of right jaw sensitive to touch, right lymph node sensitive/ eye, chin, jaw sensitivity to touch; headache on right side of head.; right eye painful; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 30Sep2021 (Lot number: FF2587) at the age of 54 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), administered in arm left, administration date 30Sep2021 (Batch/Lot number: unknown) as dose 1, single. Relevant medical history included: "Allergy: Shellfish" (unspecified if ongoing), notes: known allergies : Yes. Penicillin, ibuprofen, shellfish; "Allergy: Penicillin" (unspecified if ongoing), notes: known allergies : Yes. Penicillin, ibuprofen, shellfish. The patient's concomitant medications were not reported. Past drug history included: Ibuprofen, reaction(s): "Known Allergies: Ibuprofen", notes: known allergies : Yes. Penicillin, ibuprofen, shellfish. Vaccination history included: Bnt162b3 (Dose Number: 2, Batch/Lot No: PN6207, Location of injection: Arm Right), administration date: 14Mar2021, when the patient was 54 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6203), administration date: 20Feb2021, when the patient was 54 years old, for Covid-19 immunization. The following information was reported: TRIGEMINAL NERVE DISORDER (non-serious) with onset 07Oct2021 14:00, outcome "not recovered", described as "Trigeminal Nerve seems to be affected"; SENSORY DISTURBANCE (non-serious) with onset 07Oct2021 14:00, outcome "not recovered", described as "Top of head on right side is sensitive to touch, right eye sensitive to touch, front of right jaw sensitive to touch, right lymph node sensitive/ eye, chin, jaw sensitivity to touch"; HEADACHE (non-serious) with onset 07Oct2021 14:00, outcome "not recovered", described as "headache on right side of head."; EYE PAIN (non-serious) with onset 07Oct2021 14:00, outcome "not recovered", described as "right eye painful". The events "trigeminal nerve seems to be affected", "top of head on right side is sensitive to touch, right eye sensitive to touch, front of right jaw sensitive to touch, right lymph node sensitive/ eye, chin, jaw sensitivity to touch", "headache on right side of head." and "right eye painful" were evaluated at the emergency room visit. Therapeutic measures were not taken as a result of trigeminal nerve disorder, sensory disturbance, headache, eye pain.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Palpitations, Paraesthesia, Stress, Tremor
Clinical narrative: vibration; heart racing/heart is pounding and accelerating; trembling; it is coming from her neck to her spine and vibrating in her body; she cant sleep; very stressed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101392707 (Pfizer), US-PFIZER INC-202101392784 (Pfizer).  A 55 year-old female patient received bnt162b2 (BNT162B2), administration date 23Sep2021 (Lot number: FC3182) at the age of 55 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Frozen shoulder", start date: 2021 (unspecified if ongoing), notes: Caller stated she started treatment for frozen shoulder at the end of July or beginning of August. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, Lot: FD8448), administration date: 27Aug2021, when the patient was 55 years old, for COVID-19 immunization. The following information was reported: PARAESTHESIA (non-serious) with onset 07Oct2021, outcome "unknown", described as "it is coming from her neck to her spine and vibrating in her body"; INSOMNIA (non-serious) with onset 07Oct2021, outcome "unknown", described as "she cant sleep"; VIBRATORY SENSE INCREASED (non-serious) with onset 10Oct2021, outcome "not recovered", described as "vibration"; STRESS (non-serious) with onset Oct2021, outcome "not recovered", described as "very stressed"; PALPITATIONS (non-serious) with onset 10Oct2021, outcome "not recovered", described as "heart racing/heart is pounding and accelerating"; TREMOR (non-serious) with onset 10Oct2021, outcome "not recovered", described as "trembling". The events "vibration", "very stressed" and "trembling" were evaluated at the physician office visit. The event "heart racing/heart is pounding and accelerating" was evaluated at the physician office visit and emergency room visit.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vibratory sense increased
Clinical narrative: vibration; heart racing/heart is pounding and accelerating; trembling; it is coming from her neck to her spine and vibrating in her body; she cant sleep; very stressed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101392707 (Pfizer), US-PFIZER INC-202101392784 (Pfizer).  A 55 year-old female patient received bnt162b2 (BNT162B2), administration date 23Sep2021 (Lot number: FC3182) at the age of 55 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Frozen shoulder", start date: 2021 (unspecified if ongoing), notes: Caller stated she started treatment for frozen shoulder at the end of July or beginning of August. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, Lot: FD8448), administration date: 27Aug2021, when the patient was 55 years old, for COVID-19 immunization. The following information was reported: PARAESTHESIA (non-serious) with onset 07Oct2021, outcome "unknown", described as "it is coming from her neck to her spine and vibrating in her body"; INSOMNIA (non-serious) with onset 07Oct2021, outcome "unknown", described as "she cant sleep"; VIBRATORY SENSE INCREASED (non-serious) with onset 10Oct2021, outcome "not recovered", described as "vibration"; STRESS (non-serious) with onset Oct2021, outcome "not recovered", described as "very stressed"; PALPITATIONS (non-serious) with onset 10Oct2021, outcome "not recovered", described as "heart racing/heart is pounding and accelerating"; TREMOR (non-serious) with onset 10Oct2021, outcome "not recovered", described as "trembling". The events "vibration", "very stressed" and "trembling" were evaluated at the physician office visit. The event "heart racing/heart is pounding and accelerating" was evaluated at the physician office visit and emergency room visit.  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Skin irritation
Clinical narrative: She had a mild irritation but it was tolerable; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 82 year-old female patient received bnt162b2 (BNT162B2), administered in deltoid left, administration date 22Feb2021 11:15 (Lot number: EL9262) at the age of 81 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU taken for immunisation. Vaccination history included: Bnt162b2 (Dose: 01, start time: 11:15 AM, Anatomical Location of, Anatomical location: left upper arm), administration date: 03Feb2021, when the patient was 81 years old, for COVID-19 Immunization. The following information was reported: SKIN IRRITATION (non-serious) with onset 2021, outcome "unknown", described as "She had a mild irritation but it was tolerable". The event "she had a mild irritation but it was tolerable" was evaluated at the physician office visit.  Additional info: Patient received Booster dose: 01Oct2021, about 11:15 am Lot: FY8841, thinks it was reaction started in the middle of the night on 02Oct2021. She describes the reaction that she experienced fever, chills, severe itching, and redness like she was burned. She had a severe reaction to the covid vaccine booster shot. Asking what can be done to take the heat out of her arm and stop the itching.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Perineal rash, Rash erythematous, Rash pruritic
Clinical narrative: 5 by 3 cm left supraclavicular enlarged and tender node; 5 by 3 cm left supraclavicular enlarged and tender node; Multiple linear and curvilinear pruritic red lesions up to 15 cm in size on left side of face neck back hips buttocks and left perineal area; Multiple linear and curvilinear pruritic red lesions up to 15 cm in size on left side of face neck back hips buttocks and left perineal area; Multiple linear and curvilinear pruritic red lesions up to 15 cm in size on left side of face neck back hips buttocks and left perineal area; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Oct2021 12:00 (Batch/Lot number: unknown) at the age of 65 years as dose 3 (booster) single for covid-19 immunisation. Relevant medical history included: "hypertension" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing); "allergic rhinitis" (unspecified if ongoing). Concomitant medication(s) included: DILTIAZEM; CRESTOR; CLARITIN [LORATADINE]; LEXAPRO; INFLUENZA, start date: 22Sep2021, stop date: 22Sep2021; SINGULAIR. Vaccination history included: Bnt162b2 (Dose Number: 2, product=COVID 19, brand=Pfizer, administration date=11Oct2021, administration time=12:00 PM, vaccine location=Left arm), administration date: 11Oct2021, when the patient was 64 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, product=COVID 19, brand=Pfizer, administration date=21Dec2020, administration time=04:00 PM, vaccine location=Right arm), administration date: 21Dec2020, when the patient was 64 years old, for Covid-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 13Oct2021 19:00, outcome "not recovered" and all described as "5 by 3 cm left supraclavicular enlarged and tender node"; RASH PRURITIC (non-serious), RASH ERYTHEMATOUS (non-serious), PERINEAL RASH (non-serious) all with onset 13Oct2021 19:00, outcome "not recovered" and all described as "Multiple linear and curvilinear pruritic red lesions up to 15 cm in size on left side of face neck back hips buttocks and left perineal area". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy, lymph node pain, rash pruritic, rash erythematous, perineal rash. Additional information: Patient was not pregnant at the time of vaccination. Patient had other vaccine Influenza with in 4 weeks prior to vaccination. Patient had other medications Diltiazem, Crestor, Claritin, Singulair, Lexapro within 2 weeks of vaccination. Patient had no allergies.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: 5 by 3 cm left supraclavicular enlarged and tender node; 5 by 3 cm left supraclavicular enlarged and tender node; Multiple linear and curvilinear pruritic red lesions up to 15 cm in size on left side of face neck back hips buttocks and left perineal area; Multiple linear and curvilinear pruritic red lesions up to 15 cm in size on left side of face neck back hips buttocks and left perineal area; Multiple linear and curvilinear pruritic red lesions up to 15 cm in size on left side of face neck back hips buttocks and left perineal area; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Oct2021 12:00 (Batch/Lot number: unknown) at the age of 65 years as dose 3 (booster) single for covid-19 immunisation. Relevant medical history included: "hypertension" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing); "allergic rhinitis" (unspecified if ongoing). Concomitant medication(s) included: DILTIAZEM; CRESTOR; CLARITIN [LORATADINE]; LEXAPRO; INFLUENZA, start date: 22Sep2021, stop date: 22Sep2021; SINGULAIR. Vaccination history included: Bnt162b2 (Dose Number: 2, product=COVID 19, brand=Pfizer, administration date=11Oct2021, administration time=12:00 PM, vaccine location=Left arm), administration date: 11Oct2021, when the patient was 64 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, product=COVID 19, brand=Pfizer, administration date=21Dec2020, administration time=04:00 PM, vaccine location=Right arm), administration date: 21Dec2020, when the patient was 64 years old, for Covid-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 13Oct2021 19:00, outcome "not recovered" and all described as "5 by 3 cm left supraclavicular enlarged and tender node"; RASH PRURITIC (non-serious), RASH ERYTHEMATOUS (non-serious), PERINEAL RASH (non-serious) all with onset 13Oct2021 19:00, outcome "not recovered" and all described as "Multiple linear and curvilinear pruritic red lesions up to 15 cm in size on left side of face neck back hips buttocks and left perineal area". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy, lymph node pain, rash pruritic, rash erythematous, perineal rash. Additional information: Patient was not pregnant at the time of vaccination. Patient had other vaccine Influenza with in 4 weeks prior to vaccination. Patient had other medications Diltiazem, Crestor, Claritin, Singulair, Lexapro within 2 weeks of vaccination. Patient had no allergies.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101426722. A 70 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Oct2021 15:00 (Batch/Lot number: unknown) at the age of 70 years as dose 3 (booster), single for Covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing), notes: Verbatim: Blood pressure high; "Glaucoma" (unspecified if ongoing), notes: Verbatim: Glaucoma; "basal cell skin cancer" (unspecified if ongoing), notes: Verbatim: basal cell skin cancer, The caller had surgery on this. Concomitant medication(s) included: FLU; HYDROCHLORZIDE; TIMOLOL; TYLENOL. Vaccination history included: Bnt162b2 (1st Dose), administration date: 07Mar2021, when the patient was 70 years old, for COVID-19 immunization; Bnt162b2 (2nd Dose), administration date: 28Mar2021, when the patient was 70 years old, for Covid-19 Immunization, reaction(s): "chilled". The following information was reported: RASH PRURITIC (non-serious) with onset 20Oct2021, outcome "not recovered", described as "Third dose: her arm has a spot that is hard as a rock and red and itches"; VACCINATION SITE ERYTHEMA (non-serious) with onset 20Oct2021, outcome "not recovered", described as "Third dose: her arm has a spot that is hard as a rock and red and itches/she experienced hardness at the injection site like a rock, soreness, redness and itching"; VACCINATION SITE PAIN (non-serious) with onset 20Oct2021, outcome "unknown", described as "caller's arm was a little sore/she experienced hardness at the injection site like a rock, soreness"; VACCINATION SITE PRURITUS (non-serious) with onset 20Oct2021, outcome "unknown", described as "she experienced hardness at the injection site like a rock, soreness, redness and itching". Additional Information: Additional vaccines administered on same day was reported as none. Caller reports receiving booster dose of Pfizer Covid vaccine 19Oct2021, one day after vaccine she experienced hardness at the injection site like a rock, soreness, redness and itching. Caller asked if the vaccine is effective or is it locked in one location in her arm. Caller stated the site is 2-2 1/2 inches in diameter. On the Thursday before the caller got the third dose of the Covid vaccine, she got a flu shot in the same arm and her arm was fine at the time. The caller doesn't know the name of the flu vaccine but it was the high dose. After the caller's flu vaccine, she may have had a slightly sore arm but it was not hard, red, or itchy. This lasted for about a day and then it was fine. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Sender's Comments: Linked Report(s): US-PFIZER INC-202101426744 Same patient and drug, different event separated in time
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Arm sore for a long time at injection site after second dose of vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2), administration date 26Mar2021 11:00 (Batch/Lot number: unknown) at the age of 71 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), administration date: 05Mar2021, when the patient was 71 years old, for COVID-19 Immunization, reaction(s): "COVID-19". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "Arm sore for a long time at injection site after second dose of vaccine". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: She had some stiffness in her neck; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76 year-old female patient received bnt162b2 (BNT162B2), administration date 10Feb2021 (Lot number: EL9262) at the age of 76 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Traumatic slip on a wet floor and she broke her elbow" (unspecified if ongoing), notes: About three years ago the caller had a traumatic slip on a wet floor and she broke her elbow; "Neck was a problem" (unspecified if ongoing), notes: If the caller had a regular passing whatever or if her neck was a problem she would take some Tylenol. Concomitant medication(s) included: LEVOTHYROXINE; HYDROCHLOROTHIAZIDE; AMLODIPINE; ATORVASTATIN; VITAMIN D3. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious) with onset 2021, outcome "recovering", described as "She had some stiffness in her neck". Therapeutic measures were taken as a result of musculoskeletal stiffness.  Additional information: The caller is currently 77 years old and is calling about the Pfizer covid 19 vaccine. The caller had her first dose of the vaccine and the second dose was on the 03Mar2021. The caller thinks that this is probably related, she is not sure if she was predisposed to this but she was having physical therapy for her neck because she had some stiffness in her neck prior to receiving the second dose of the vaccine. The caller was about to be released from physical therapy before she got her second vaccine. Before the second dose of the vaccine the caller had increased range of motion in her neck and it was much better. Then after the second dose, the caller's neck pain increased and she is still not back to where she was. It could be related to the vaccine but the caller isn't sure because her neck stiffness and pain went away when her headache went away. The caller noted in her journal minimum pain in her neck and pain in her head on 15Aug2021 and then no head pain starting on 16Aug2021 and the same thing over and over again. The caller took Tylenol and Ibuprofen that didn't help. The caller is still in physical therapy because she still has pain in her neck that she didn't have that before all of this. The neck pain and stiffness happened around the same time as headaches.  About three years ago the caller had a traumatic slip on a wet floor and she broke her elbow. Now the caller has a lot of metal and tin in her forearm but she doesn't think that that would cause this neck pain. The call has pain the left side of her neck and it is related to the left arm. The caller recently heard that the Moderna booster is like half the dose of the other vaccine because its a booster and has fewer side effects. Is that true for the Pfizer booster dose. When the caller heard this she wanted to get the and if she heard it was less of the vaccine and she knows that you can't mix and match vaccines.   Follow-up attempts are completed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraines that last three days which started the day after getting the vaccine and has happened twice a month since then; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 17Aug2021 13:00 (Lot number: FD8448) at the age of 26 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SERTRALINE. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FA7485, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 14Jul2021, when the patient was 26 years old, for COVID-19 immunization. The following information was reported: MIGRAINE (non-serious) with onset 18Aug2021 12:00, outcome "not recovered", described as "Migraines that last three days which started the day after getting the vaccine and has happened twice a month since then". Therapeutic measures were not taken as a result of migraine. No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Fatigue, Influenza like illness, Lymph node pain
Clinical narrative: cough; Painful swollen lymph node in armpit near injection site size of a large gumball; Painful swollen lymph node in armpit near injection site size of a large gumball; flu-like symptoms; fatigue for 4 days; shortness of breathe; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), administered in arm left, administration date 01Nov2021 (Lot number: FD0809) at the age of 48 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing); "Allergy" (unspecified if ongoing). Concomitant medication(s) included: ZINC; PHYTOESTROGEN; MAGNESIUM. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: 30155BA, Location of injection: Arm Left, 1st dose: mouth sores/blisters (1+ week), metallic taste (2 days)), administration date: 11Oct2021, when the patient was 48 years old, for COVID-19 immunization, reaction(s): "mouth sores/blisters", "mouth sores/blisters"; Bnt162b2 (Dose Number: 1, Batch/Lot No: 30155BA, Location of injection: Arm Left, 1st dose: mouth sores/blisters (1+ week), metallic taste (2 days)), when the patient was 48 years old, for COVID-19 immunization, reaction(s): "metallic taste". The following information was reported: COUGH (non-serious) with onset 02Nov2021, outcome "recovered", described as "cough"; LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 02Nov2021, outcome "recovered" and all described as "Painful swollen lymph node in armpit near injection site size of a large gumball"; INFLUENZA LIKE ILLNESS (non-serious) with onset 02Nov2021, outcome "recovered", described as "flu-like symptoms"; FATIGUE (non-serious) with onset 02Nov2021, outcome "recovered" (04Nov2021), described as "fatigue for 4 days"; DYSPNOEA (non-serious) with onset 02Nov2021, outcome "recovered", described as "shortness of breathe". The events "cough", "painful swollen lymph node in armpit near injection site size of a large gumball", "flu-like symptoms", "fatigue for 4 days", "shortness of breathe" and "painful swollen lymph node in armpit near injection site size of a large gumball" were evaluated at the physician office visit.  Additional information: Patient did not receive any other vaccine in four weeks, Other medications in two weeks include multi-vitamin, Patient did not had covid prior vaccination, patient not tested for covid post vaccination. Clinical course: After 1st dose mouth sores/blisters (1+ week), metallic taste (2 days), After 2nd dose Painful swollen lymph node in armpit near injection site size of a large gumball, flu-like symptoms and fatigue for 4 days, & shortness of breathe and cough for a month.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101849397 similar report from same reporter
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: cough; Painful swollen lymph node in armpit near injection site size of a large gumball; Painful swollen lymph node in armpit near injection site size of a large gumball; flu-like symptoms; fatigue for 4 days; shortness of breathe; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), administered in arm left, administration date 01Nov2021 (Lot number: FD0809) at the age of 48 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing); "Allergy" (unspecified if ongoing). Concomitant medication(s) included: ZINC; PHYTOESTROGEN; MAGNESIUM. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: 30155BA, Location of injection: Arm Left, 1st dose: mouth sores/blisters (1+ week), metallic taste (2 days)), administration date: 11Oct2021, when the patient was 48 years old, for COVID-19 immunization, reaction(s): "mouth sores/blisters", "mouth sores/blisters"; Bnt162b2 (Dose Number: 1, Batch/Lot No: 30155BA, Location of injection: Arm Left, 1st dose: mouth sores/blisters (1+ week), metallic taste (2 days)), when the patient was 48 years old, for COVID-19 immunization, reaction(s): "metallic taste". The following information was reported: COUGH (non-serious) with onset 02Nov2021, outcome "recovered", described as "cough"; LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 02Nov2021, outcome "recovered" and all described as "Painful swollen lymph node in armpit near injection site size of a large gumball"; INFLUENZA LIKE ILLNESS (non-serious) with onset 02Nov2021, outcome "recovered", described as "flu-like symptoms"; FATIGUE (non-serious) with onset 02Nov2021, outcome "recovered" (04Nov2021), described as "fatigue for 4 days"; DYSPNOEA (non-serious) with onset 02Nov2021, outcome "recovered", described as "shortness of breathe". The events "cough", "painful swollen lymph node in armpit near injection site size of a large gumball", "flu-like symptoms", "fatigue for 4 days", "shortness of breathe" and "painful swollen lymph node in armpit near injection site size of a large gumball" were evaluated at the physician office visit.  Additional information: Patient did not receive any other vaccine in four weeks, Other medications in two weeks include multi-vitamin, Patient did not had covid prior vaccination, patient not tested for covid post vaccination. Clinical course: After 1st dose mouth sores/blisters (1+ week), metallic taste (2 days), After 2nd dose Painful swollen lymph node in armpit near injection site size of a large gumball, flu-like symptoms and fatigue for 4 days, & shortness of breathe and cough for a month.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101849397 similar report from same reporter
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Sore throat; The initial case was missing the following minimum criteria: no adverse effect. upon receipt of follow-up information on (30Sep2021), this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 76 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Single), administration date: 20Jan2021, for COVID-19 immunization, reaction(s): "Swelling arm". The following information was reported: OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "Sore throat". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Blood test, Computerised tomogram, Dehydration, Dizziness
Clinical narrative: Reaction to the vaccine; Dizziness; Trobule speaking; Dehydrated; This is a spontaneous report received from a contactable reporter(s) (Other HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A 63 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 28Jan2021 14:00 (Lot number: EN5318) at the age of 63 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Pancreatitis", start date: 2015 (ongoing), notes: No symptom doing good, Normal; "Skin cancer" (ongoing), notes: At least 30 years ago, Doing good, Normal; "BP" (ongoing), notes: Last 20 years ago, Normal Losartan; "Cholesterol" (ongoing), notes: 20 Years, Normal pravastatin. Concomitant medication(s) included: LOSARTAN taken for blood pressure abnormal (ongoing); PRAVASTATIN taken for blood cholesterol (ongoing). Vaccination history included: Bnt162b2 (DOSE 1, SINGLE., Product Name/Manufacturer: Pfizer Biontech, Time: 02:00 PM, Anatomical location: Right arm, Lot Number: EK4176), administration date: 06Jan2021, when the patient was 63 years old, for COVID-19 immunization. The following information was reported: VACCINATION SITE REACTION (non-serious) with onset 28Jan2021, outcome "recovered" (2021), described as "Reaction to the vaccine"; DIZZINESS (non-serious) with onset 28Jan2021, outcome "recovered" (2021), described as "Dizziness"; SPEECH DISORDER (non-serious) with onset 28Jan2021, outcome "recovered" (2021), described as "Trobule speaking"; DEHYDRATION (non-serious) with onset 28Jan2021, outcome "unknown", described as "Dehydrated". The events "reaction to the vaccine", "dizziness" and "trobule speaking" were evaluated at the physician office visit and emergency room visit. The event "dehydrated" was evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient did not had any prior vaccinations. It was reported that the Pfizer product had a causal effect to the adverse event.  Follow-up attempts are completed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder, Vaccination site reaction
Clinical narrative: Reaction to the vaccine; Dizziness; Trobule speaking; Dehydrated; This is a spontaneous report received from a contactable reporter(s) (Other HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A 63 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 28Jan2021 14:00 (Lot number: EN5318) at the age of 63 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Pancreatitis", start date: 2015 (ongoing), notes: No symptom doing good, Normal; "Skin cancer" (ongoing), notes: At least 30 years ago, Doing good, Normal; "BP" (ongoing), notes: Last 20 years ago, Normal Losartan; "Cholesterol" (ongoing), notes: 20 Years, Normal pravastatin. Concomitant medication(s) included: LOSARTAN taken for blood pressure abnormal (ongoing); PRAVASTATIN taken for blood cholesterol (ongoing). Vaccination history included: Bnt162b2 (DOSE 1, SINGLE., Product Name/Manufacturer: Pfizer Biontech, Time: 02:00 PM, Anatomical location: Right arm, Lot Number: EK4176), administration date: 06Jan2021, when the patient was 63 years old, for COVID-19 immunization. The following information was reported: VACCINATION SITE REACTION (non-serious) with onset 28Jan2021, outcome "recovered" (2021), described as "Reaction to the vaccine"; DIZZINESS (non-serious) with onset 28Jan2021, outcome "recovered" (2021), described as "Dizziness"; SPEECH DISORDER (non-serious) with onset 28Jan2021, outcome "recovered" (2021), described as "Trobule speaking"; DEHYDRATION (non-serious) with onset 28Jan2021, outcome "unknown", described as "Dehydrated". The events "reaction to the vaccine", "dizziness" and "trobule speaking" were evaluated at the physician office visit and emergency room visit. The event "dehydrated" was evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient did not had any prior vaccinations. It was reported that the Pfizer product had a causal effect to the adverse event.  Follow-up attempts are completed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Breast swelling, Mammogram
Clinical narrative: breast swelling; Pain; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Aug2021 10:00 (Lot number: EW1086) at the age of 54 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "pcn" (unspecified if ongoing), notes: known allergies: pcn. There were no concomitant medications. The following information was reported: BREAST SWELLING (non-serious) with onset 25Aug2021, outcome "recovered" (2021), described as "breast swelling"; BREAST PAIN (non-serious) with onset 25Aug2021, outcome "recovered" (2021), described as "Pain". The events "breast swelling" and "pain" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of breast swelling, breast pain.  Additional information: If Other vaccine in four weeks: No. Other medications in two weeks none. if Covid prior vaccination: No if Covid tested post vaccination: No. known allergies pcn. Other medical history none. 36 hours after vaccine #1 - breast swelling on OTHER side - not side with vaccine. Pain and swelling continued. I went for mammogram - everything was fine. Symptoms took about 3-4 weeks to resolve. Hesitant to receive #2 - but did and exact same thing happened. Still with breast pain and tenderness.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for Covid-19 Immunization. The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "vertigo". The lot number for bnt162b2 was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Body height, Dizziness, Vertigo
Clinical narrative: vertigo; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for Covid-19 Immunization. The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "vertigo". The lot number for bnt162b2 was not provided and will be requested during follow up.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: She was feeling a little off balance; Vertigo; She just had a little dizziness.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Oct2021 (Lot number: FH8020) at the age of 56 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing), notes: She is on a high blood pressure medication. Concomitant medication(s) included: ENALAPRIL+HCTZ taken for hypertension (ongoing). Vaccination history included: Bnt162b2 (lot number 30155BA, left arm), administration date: 07Oct2021, when the patient was 56 years old, for Covid-19 immunization. The following information was reported: VERTIGO (non-serious) with onset 03Nov2021 11:00, outcome "not recovered", described as "Vertigo"; DIZZINESS (non-serious) with onset 03Nov2021, outcome "unknown", described as "She just had a little dizziness."; BALANCE DISORDER (non-serious), outcome "unknown", described as "She was feeling a little off balance". Relevant laboratory tests and procedures are available in the appropriate section.  Follow-up (11Nov2021): Follow-up attempts completed. No further information expected. No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Body height, Dizziness, Vertigo
Clinical narrative: She was feeling a little off balance; Vertigo; She just had a little dizziness.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Oct2021 (Lot number: FH8020) at the age of 56 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing), notes: She is on a high blood pressure medication. Concomitant medication(s) included: ENALAPRIL+HCTZ taken for hypertension (ongoing). Vaccination history included: Bnt162b2 (lot number 30155BA, left arm), administration date: 07Oct2021, when the patient was 56 years old, for Covid-19 immunization. The following information was reported: VERTIGO (non-serious) with onset 03Nov2021 11:00, outcome "not recovered", described as "Vertigo"; DIZZINESS (non-serious) with onset 03Nov2021, outcome "unknown", described as "She just had a little dizziness."; BALANCE DISORDER (non-serious), outcome "unknown", described as "She was feeling a little off balance". Relevant laboratory tests and procedures are available in the appropriate section.  Follow-up (11Nov2021): Follow-up attempts completed. No further information expected. No follow-up attempts are possible. No further information is expected.